Liminatus Pharma LIMN
NASDAQ LIMN
$3.88 +0.13 (+3.46%)
As of: Oct 2, 2026 · 1:03 PM EDT

Liminatus Pharma (LIMN) Price to Book (2026)

Updated

Liminatus Pharma's (LIMN) Price to Book stood at 20.48 in Q2 2026.

Analysis

Liminatus Pharma (LIMN) Price to Book (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Liminatus Pharma 4.18 Mn 4.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.48
API Access

Liminatus Pharma Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=LIMN&period=max&api_key=YOUR_API_KEY